GLP1R and type 2 diabetes mellitus: To further validate the in vitro findings, an STZ-induced T2DM model in rats was established, and RYGB surgery was performed on T2DM rats, or T2DM rats were alternatively treated with GLP-1R agonist EX-4 and examined glucose metabolism- and lipid metabolism-related indicators were examined.